Restrictions on generic drugs “infringe the right to health”BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c7246 (Published 16 December 2010) Cite this as: BMJ 2010;341:c7246
- Peter Moszynski
A free trade agreement currently being negotiated between the European Union and India threatens India’s production of cheap generic drugs, according to the UN special rapporteur on the Right to Health and other officials and campaigners.
Special rapporteur Anand Grover said in a 10 December press statement: “Millions in the developing world depend on India for generic medicines at affordable costs. Restriction of generic drug production in India will have a devastating public health impact around the world and adversely affect the right to health of millions of patients.”
He said that if the intellectual property provisions remain in the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial